Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles Genes and Development Year : 2015

Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo

Abstract

Inactivation of phosphatase and tensin homology deleted on chromosome 10 (PTEN) is linked to increased PI3K–AKT signaling, enhanced organismal growth, and cancer development. Here we generated and analyzed Pten knock-in mice harboring a C2 domain missense mutation at phenylalanine 341 (PtenFV), found in human cancer. Despite having reduced levels of PTEN protein, homozygous PtenFV/FV embryos have intact AKT signaling, develop normally, and are carried to term. Heterozygous PtenFV/+ mice develop carcinoma in the thymus, stomach, adrenal medulla, and mammary gland but not in other organs typically sensitive to Pten deficiency, including the thyroid, prostate, and uterus. Progression to carcinoma in sensitive organs ensues in the absence of overt AKT activation. Carcinoma in the uterus, a cancer-resistant organ, requires a second clonal event associated with the spontaneous activation of AKT and downstream signaling. In summary, this PTEN noncatalytic missense mutation exposes a core tumor suppressor function distinct from inhibition of canonical AKT signaling that predisposes to organ-selective cancer development in vivo.

Dates and versions

hal-01244933 , version 1 (16-12-2015)

Identifiers

Cite

Enrico Caserta, Onur Egriboz, Hui Wang, Chelsea Martin, Christopher Koivisto, et al.. Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes and Development, 2015, ⟨10.1101/gad.262568.115⟩. ⟨hal-01244933⟩

Collections

INRIA INRIA2
74 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More